Suven Life Sciences Ltd. company information, Employees & Contact Information

Why Suven Life Sciences Share Price is Rising Equitymaster

Suven Pharmaceuticals is now Cohance Lifesciences Indian Pharma Post

Venkat Jasti’s billion-dollar gamble: Can Suven Life crack the CNS drug puzzle? Moneycontrol

Will Suven Life Sciences (NSE:SUVEN) Spend Its Cash Wisely? simplywall.st

Suven Pharmaceuticals acquires controlling stake in US-based NJ Bio CNBC TV18

Suven Pharma to acquire majority stake in US-based NJ Bio Business Standard

Samelisant Shows Potential as a Treatment for Excessive Daytime Sleepiness in Parkinson Disease NeurologyLive

Its official: Suven Pharma and Cohance Lifesciences merger to take effect from May 1 financialexpress.com

NCLT approves amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals Indian Pharma Post

Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease ACS Publications

Suven Pharma acquires 56% stake in US-based NJ Bio Times of India

NCLT approves amalgamation of Suven Pharma, Cohance Lifesciences Business Standard

Suven Pharmaceuticals rebrands as Cohance Lifesciences bestmediainfo.com

Advent-controlled Suven Pharma appoints former Piramal exec as chairman VCCircle

Hyderabad-based drug manufacturer Suven to acquire majority stake in NJ Bio for $64 million The New Indian Express

Suven Pharmaceuticals get final approval to amalgamate Cohance Lifesciences Indian Pharma Post

Suven Pharma acquires majority stake in US-based NJ Bio Moneycontrol

NCLT sanctions amalgamation of Cohance Lifesciences into Suven Pharmaceuticals Times of India

Suven Life Sciences to present positive results from Phase-2a Proof-of-Concept Study of Ropanicant Indian Pharma Post

Suven to acquire a majority stake in CDMO player ‘Sapala Organics’ Indian Pharma Post

DoP clears Suven Pharma, Cohance Lifesciences merger ET Pharma

NCLT approves Suven Pharma and Cohance Lifesciences Merger ET Pharma

Suven Life hits life high after positive result for its depression drug Business Standard

Cohance Lifesciences merger with Suven Pharma gets NSE, BSE nod Times of India

Cohance Lifesciences to merge with Suven Pharma Times of India

Suven Pharma hits record high on USFDA's 'VAI' tag to Hyderabad facility Business Standard

Advent International buys Suven Pharma for Rs 6,313 crore The Economic Times

Suven Pharmaceuticals names Vivek Sharma as executive chairman The Economic Times

Hyderabad-based Suven Life’s Q4 net loss widens to Rs 43.9 crore Telangana Today

Suven Pharma to acquire 67.5% stake in Sapala Organics for Rs 229.5 cr Business Standard

Suven starts Phase 3 trial for first home-grown Alzheimer's drug Business Standard

Sunil Singhania, Prashant Jain invest in Suven Life preferential issue; stock jumps 12% CNBC TV18

Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT Express Pharma

Suven Pharma zooms 12% on merger with Cohance Lifesciences Moneycontrol

Advent closes in on Suven Pharma buyout The Economic Times

Advent International to acquire 50.1% stake in Suven Pharma, explore merger Business Standard

Suven-Cohance Lifesciences merger announced to create 1st listed PE-led contract manufacturer in Indian ph The Economic Times

Advent PE begins merger process of Suven Pharma and Cohance Lifesciences Business Standard

Cash Market | A breakout trade in Suven Life Science Moneycontrol

JSA advises on $3 billion Suven Pharma–Cohance Lifesciences merger Bar and Bench

Suven Pharma and Cohance Lifesciences announce merger BusinessLine

Molecule key to Alzeimer's treatment will show results in 2025, says Suven Life CNBC TV18

PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake Business Today

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India Indian Pharma Post

Advent acquires 50.1% in Suven Pharma, open offer for additional 26% ahead The Hindu

Suven Pharmaceuticals Share Price Today Live Updates, 13 Feb, 2025: Suven Pharmaceuticals on the radar financialexpress.com

Suven, Cohance aim to double combined biz revenue to Rs 6,000 cr by FY29 Business Standard

Suven Pharma to merge with Cohance Lifesciences Zee Business

Suven Pharmaceuticals shares: Swap ratio, merger timeline, management view & more Business Today

Exclusive: Suven Pharma promoters plan to sell entire stake Zee Business

Mid-cap Picks with Anil Singhvi: Suven Pharma, Graphite India, Vinati Organics are stocks to buy for high returns, says Siddharth Sedani Zee Business

Cohance Lifesciences, The New Identity Of Suven Pharmaceuticals Passionate In Marketing